Apervita, Inc. (www.apervita.com), the first health analytics market, today announced it was voted “most likely to make the biggest immediate impact on digital health” by industry partners and advisors at HealthXL (www.healthxl.org), the global clearing house for innovation in healthcare. More than 60 HealthXL community members from major global health enterprises cast their votes for 20 innovative health companies featured in the HealthXL Report. Among the shortlisted companies included in the report, Apervita collected the most votes for its platform enabling rapid self-service publishing of health analytics. Apervita will now present at the HealthXL event in Dublin on February 27 to some of the largest healthcare corporations in the world, such as IBM, Novartis and Linde Healthcare.

“Our mission is to catalyze collaboration between leading brands in healthcare and the most exciting tech companies to improve the lives of millions of people.” said Martin Kelly, CEO and Founder of HealthXL. “We are delighted that Apervita will present in front of 70 global healthcare leaders at the Global Gathering. With its healthcare analytics market, Apervita is a prime example of a new cloud platform that can help countless patients worldwide.”

Apervita empowers health professionals and enterprises to capture and share health knowledge, allowing them to easily author, publish and use health analytics, such as algorithms, quality and safety measures, pathways, and protocols. The cloud-based Apervita Market enables anyone, anywhere to create and subscribe to analytics, and easily integrate them into their workflow. For the first time, it provides fast, flexible and affordable analytics necessary to satisfy the burgeoning demand for health insights. Apervita’s rapidly growing community, including top academic medical centers, are addressing fundamental provider challenges, such as chronic disease management, preventable adverse events, readmissions, cancer, early warning, quality and safety.

“Among the greatest challenges in healthcare is the time it takes to transition research from the scientist’s bench into practice. It is estimated that it takes 17 years, a number that’s unacceptable when it’s costing lives,” said Paul Magelli, CEO of Apervita. “Apervita solves this problem by offering a simple solution for authors and professionals to share and use health analytics that can quickly benefit patients. Our Moonshot at Apervita is to connect the world’s computable health knowledge to empower health professionals everywhere. We are well on our way to achieving this audacious goal.”

Apervita recently completed an $18 million Series A funding round, led by GE Ventures and Baird Capital with participation from Pritzker Group Venture Capital, Math Ventures and existing investors, to support its goal of empowering enterprises across the globe to transform health knowledge and data into computable insight, addressing healthcare’s most pressing challenges.

HealthXL is the global clearing house for innovation in healthcare. We catalyze collaboration between leading brands in healthcare and the most exciting tech companies to improve the lives of millions of people. Together with our partners we establish audacious goals (Moonshots) to work towards within healthcare. Then we search for innovators in digital health that can work with us and our partners to achieve those Moonshots. We help them find each other, create business partnerships and facilitate their relationship through collaboration. Our partners are Bupa, Cleveland Clinic, Becton Dickinson, IBM, ICON, ResMed, Janssen Healthcare Innovation, Linde Healthcare, Novartis, Partners HealthCare, Silicon Valley Bank and EY.

About Apervita

Apervita is the leading health analytics community, where prominent health professionals and enterprises from around the globe are transforming the world’s health knowledge into thousands of health analytics.

At Apervita, we believe that health researchers and practitioners have already created the greatest wealth of health knowledge that has ever existed and it is just waiting to be unleashed to improve health. Today, the majority of this knowledge is paper-based or locked into proprietary systems. The Apervita community is already unlocking them, turning them into computable and shareable analytics and putting them to work to improve health. They are addressing some of the biggest health challenges, such as the 100,000s of patients that die prematurely every year in the United States from chronic disease, complications and preventable adverse events.

Apervita is a secure, self-service platform, that enables health professionals and enterprises to author, publish and subscribe to a market of evidence-based algorithms and measures, easily connecting them to data and workflow. Available to every health professional and powerful enough for the entire health enterprise, Apervita provides health analytics at a tenth of today’s cost, in a hundredth of the time.